[Clinical study on bronchial asthma and leukotriene antagonists].
Yokoyama
Akihito
A
D000280:Administration, Inhalation; D000284:Administration, Oral; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001507:Beclomethasone / Q000008:administration & dosage; D001993:Bronchodilator Agents / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D018836:Inflammation Mediators / Q000502:physiology; D020024:Leukotriene Antagonists / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*; D015289:Leukotrienes / Q000502:physiology; D008565:Membrane Proteins / Q000037:antagonists & inhibitors / Q000502:physiology; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D018077:Receptors, Leukotriene / Q000502:physiology; D012720:Severity of Illness Index
D018927:Anti-Asthmatic Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D018836:Inflammation Mediators; D020024:Leukotriene Antagonists; D015289:Leukotrienes; D008565:Membrane Proteins; D018077:Receptors, Leukotriene; D001507:Beclomethasone; C083169:leukotriene D4 receptor